Agencies
Services
Drugs and Therapeutics (D & T) Committee Meeting Results* for: March 26, 2008
| Drug Name | Review Type | Committee Recommendation | Prior Approval Status � Final Determination |
|---|---|---|---|
| Combigan | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
| Iquix | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
| Lipofen | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
| ProAir HFA | PDL Appeal | Remain Non-Preferred | Non-Preferred � PDL Class |
| Saizen | PDL Appeal | Remain Non-Preferred | Non-Preferred � PDL Class |
| Sanctura XR | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
| Simcor | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
| Tekturna | New Drug Initial Review | Require Prior Approval | Prior Approval Required |
| Vusion | New Drug Initial Review | Require Prior Approval | Prior Approval Required |